Innovation in cardiovascular pharmacology for the interventional cardiologist

Chairperson: R. Kornowski
Co-chairperson: P.G. Steg

Learning Objectives

  • To be updated on emerging cardiovascular pharmacotherapy
  • To recognise new drugs and medications undergoing late-phase clinical trials
  • To appreciate interactions between current and future pharmacologic interventions

Presentations available when logged in:

  • Injectable antithrombotics
  • Oral antithrombotics
  • Anti-inflammatory agents
  • Post-conditioning pharmacology
  • Lipid modifying agents: LDL reducers and HDL augmenters
  • Session evaluation and key learnings